-Search query
-Search result
Showing 1 - 50 of 172 items for (author: rotty & b)
EMDB-40242:
BG505 MD39 SOSIP in complex with Rh.NJ85 wk12 gp120GH, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40243:
BG505 MD39 SOSIP in complex with Rh.NJ86 wk12 V1V3, C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40244:
BG505 MD39 SOSIP in complex with Rh.NJ76 wk12 C3V5, N611/FP, and base epitope polyclonal antibodies
Method: single particle / : Lee WH, Ozorowski G, Torres JL, Ward AB
EMDB-40252:
BG505 MD39 SOSIP in complex with Rh.NK04 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40254:
BG505 MD39 SOSIP in complex with Rh.NJ75 wk12 gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40255:
BG505 MD39 SOSIP in complex with Rh.NJ87 wk12 C3V5 and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40256:
BG505 MD39 SOSIP in complex with Rh.NJ84 wk12 V1V3, gp120 glycan hole and base epitope polyclonal antibodies
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40257:
BG505 MD39 SOSIP in complex with Rh.NJ77 wk12 V1V3, C3V5, N611/FP and base epitope polyclonal
Method: single particle / : Lee WS, Ozorowski G, Torres JL, Ward AB
EMDB-40803:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40804:
BG505 Boost2 SOSIP.664 in complex with NHP Polyclonal Antibody FP4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40805:
BG505 Boost 2 in complex with NHP antibody V1V2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40806:
BG505 Boost 2 in complex with NHP Polyclonal Antibody N625
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40807:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base1
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40808:
Boost 2 SOSIP.664 in complex with NHP polyclonal antibody Base2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40809:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40810:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sw7:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-27538:
Lymphocytic choriomeningitis virus glycoprotein in complex with neutralizing antibody M28
Method: single particle / : Moon-Walker A, Hastie KM, Zyla DS, Saphire EO
EMDB-27539:
Lymphocytic choriomeningitis virus glycoprotein
Method: single particle / : Moon-Walker A, Hastie KM, Zyla DS, Saphire EO
PDB-8dmh:
Lymphocytic choriomeningitis virus glycoprotein in complex with neutralizing antibody M28
Method: single particle / : Moon-Walker A, Hastie KM, Zyla DS, Saphire EO
PDB-8dmi:
Lymphocytic choriomeningitis virus glycoprotein
Method: single particle / : Moon-Walker A, Hastie KM, Zyla DS, Saphire EO
EMDB-27779:
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8dya:
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-27610:
BG505 MD39 SOSIP in complex with Rh.NJ82 wk13 N611 and base epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27611:
BG505 MD39 SOSIP in complex with Rh.NJ95 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27612:
BG505 MD39 SOSIP in complex with Rh.NK05 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27614:
BG505 MD39 SOSIP in complex with Rh.NJ79 wk13 base epitope pAb
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27615:
BG505 MD39 SOSIP in complex with Rh.NJ93 wk13 base and V5/C3 epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27601:
BG505 MD39 SOSIP in complex with Rh.K409 wk13 base, FP/gp41, V5/C3 and N611 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27602:
BG505 MD39 SOSIP in complex with Rh.K487 wk13 base, FP/gp41, and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27603:
BG505 MD39 SOSIP in complex with Rh.DGT5 wk13 base, N335/N289, V1/V3 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27604:
BG505 MD39 SOSIP in complex with Rh.K949 wk33 base, N335/N289, V1/V3, N611 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27605:
BG505 MD39 SOSIP in complex with Rh.L282 wk33 base, N335/N289, FP/gp41 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27607:
BG505 MD39 SOSIP in complex with Rh.DHHT wk33 base, FP/gp41 and V5/C3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27608:
BG505 MD39 SOSIP in complex with Rh.DHID wk33 base, N355/N289 and V1/V3 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-27609:
BG505 MD39 SOSIP in complex with Rh.NJ78 wk13 V5/C3 and base epitope pAbs
Method: single particle / : Torres JL, Lee WH, Ozorowski G, Ward AB
EMDB-27600:
BG505 MD39 SOSIP in complex with Rh.L614 wk13 base, N335/N289, V5/C3 and N611 epitope pAbs
Method: single particle / : Sewall LM, Richey ST, Ozorowski G, Ward AB
EMDB-26522:
SARS-CoV-2 6P Mut7 in complex with K398.25 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26523:
SARS-CoV-1 in complex with K398.25 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26524:
SARS-CoV-2 6P Mut7 in complex with K398.16 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26525:
SARS-CoV-2 6P Mut7 in complex with K398.16 Fab (3 bound)
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26526:
SARS-CoV-1 in complex with K398.16 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26527:
SARS-CoV-2 6P Mut7 in complex with K288.2 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26528:
SARS-CoV-2 6P Mut7 in complex with K398.8 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26529:
SARS-CoV-2 6P Mut7 in complex with K398.8 Fab (2 bound)
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26530:
SARS-CoV-2 6P Mut7 in complex with K398.18 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26531:
SARS-CoV-2 6P Mut7 in complex with K398.18 Fabs (2 bound)
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26532:
SARS-CoV-2 6P Mut7 in complex with K398.22 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26533:
SARS-CoV-2 6P Mut7 in complex with K398.22 Fab (2 bound)
Method: single particle / : Lee WH, Torres JL, Ward AB
EMDB-26534:
SARS-CoV-1 in complex with K398.8 Fab
Method: single particle / : Lee WH, Torres JL, Ward AB
Pages: